2 completed, 2 terminated. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Terminated 2 |
Follow UAB 30: new trials by email Literature Review of UAB 30 trials Research Report on UAB 30
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer Biospecimen Collection, Retinoid 9cUAB30, Therapeutic Conventional Surgery - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Phase 1 | Terminated | National Cancer Institute (NCI) | 27 | 2018-03-16 | 2024-06-18 |
| Retinoid 9cUAB30 in Preventing Cancer in Healthy Volunteers Laboratory Biomarker Analysis, Pharmacological Study, Placebo - Healthy Subject | Phase 1 | Completed | National Cancer Institute (NCI) | 40 | 2013-08-01 | 2016-12-23 |
| Dose-Finding of Retinoid 9cUAB30 in Healthy Volunteers retinoid 9cUAB30, placebo, pharmacological study - Healthy, no Evidence of Disease | Phase 1 | Terminated | National Cancer Institute (NCI) | 50 | 2011-10-01 | 2014-10-09 |
| Study of 9cUAB30 in Healthy Participants Laboratory Biomarker Analysis, Pharmacological Study, Retinoid 9cUAB30 - No Evidence of Disease | Phase 1 | Completed | National Cancer Institute (NCI) | 15 | 2008-08-01 | 2015-06-18 |
Carcinoma, Intraductal, Noninfiltrating (1)
National Cancer Institute (NCI) (4)
United States (4)
Jill Kolesar (2) · Helen Krontiras (1) · Howard Bailey (1)
N01CN35153 (3), P30CA014520 (3), N01CN00033 (1)